Eli Lilly Sues FDA Over Diabetes Medication Compounding Rule
Eli Lilly, maker of popular diabetes medications Mounjaro and Zepbound, is taking legal action against the US Food and Drug Administration (FDA) over a rule change that allows compounding pharmacies to continue producing counterfeit versions of its drugs. Lilly filed a motion to intervene in a lawsuit brought by the Outsourcing Facilities Association (OFA) and … Read more